TY - JOUR
T1 - Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002
AU - Shulman, Stanford T.
AU - Tanz, Robert B.
AU - Kabat, William
AU - Kabat, Kathleen
AU - Cederlund, Emily
AU - Patel, Devendra
AU - Li, Zhongya
AU - Sakota, Varja
AU - Dale, James B.
AU - Beall, Bernard
PY - 2004/8/1
Y1 - 2004/8/1
N2 - Geographic and interseasonal heterogeneity of pharyngeal group A streptococcal (GAS) genotypes (emm types) is poorly characterized. We evaluated emm type and subtype distribution among pediatric pharyngitis isolates obtained from 9 sites in the United States during 2000-2001 (year 1) and from 10 sites in the United States and 1 site in Canada during 2001-2002 (year 2). The 7 predominant types were the same in both years, although their order changed, emm 12, 1, and 28 accounted for 49.2% of year 1 isolates, and emm 1, 12, and 4 accounted for 47.1% of year 2 isolates; 6 types accounted for 72.1% in year 1 and 69.4% in year 2. From year 1 to year 2, the proportions of emm 12 and 28 decreased and emm 1 and 6 increased. Striking intersite and interseasonal variations in the distribution of predominant emm types were observed. We conclude that the most-predominant GAS genotypes were similar for each year despite fluctuations, that intersite and intrasite variations in the distribution of emm types were apparent, and that emm type surveillance is needed as M protein vaccine development proceeds.
AB - Geographic and interseasonal heterogeneity of pharyngeal group A streptococcal (GAS) genotypes (emm types) is poorly characterized. We evaluated emm type and subtype distribution among pediatric pharyngitis isolates obtained from 9 sites in the United States during 2000-2001 (year 1) and from 10 sites in the United States and 1 site in Canada during 2001-2002 (year 2). The 7 predominant types were the same in both years, although their order changed, emm 12, 1, and 28 accounted for 49.2% of year 1 isolates, and emm 1, 12, and 4 accounted for 47.1% of year 2 isolates; 6 types accounted for 72.1% in year 1 and 69.4% in year 2. From year 1 to year 2, the proportions of emm 12 and 28 decreased and emm 1 and 6 increased. Striking intersite and interseasonal variations in the distribution of predominant emm types were observed. We conclude that the most-predominant GAS genotypes were similar for each year despite fluctuations, that intersite and intrasite variations in the distribution of emm types were apparent, and that emm type surveillance is needed as M protein vaccine development proceeds.
UR - http://www.scopus.com/inward/record.url?scp=3943092598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3943092598&partnerID=8YFLogxK
U2 - 10.1086/421949
DO - 10.1086/421949
M3 - Article
C2 - 15306998
AN - SCOPUS:3943092598
SN - 1058-4838
VL - 39
SP - 325
EP - 332
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 3
ER -